Johnson & Johnson Neuro Pace Inc Call Options Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NPCE
# of Institutions
52Shares Held
21.3MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.62MShares$57.3 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$34.7 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$25.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$24.8 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$12.8 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $253M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...